Vanda Pharmaceuticals
VNDA
#7419
Rank
NZ$0.73 B
Marketcap
NZ$12.52
Share price
-3.08%
Change (1 day)
58.11%
Change (1 year)

Market capitalization of Vanda Pharmaceuticals (VNDA)

Market cap: NZ$0.73 Billion

As of February 2026 Vanda Pharmaceuticals has a market cap of NZ$0.73 Billion. This makes Vanda Pharmaceuticals the world's 7419th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Vanda Pharmaceuticals from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.73 B2.99%
2025NZ$0.71 B44.45%
2024NZ$0.49 B29.53%
2023NZ$0.38 B-41.72%
2022NZ$0.65 B-48.53%
2021NZ$1.27 B28.08%
2020NZ$0.99 B-23.42%
2019NZ$1.30 B-36.17%
2018NZ$2.04 B112.6%
2017NZ$0.96 B-4.98%
2016NZ$1.01 B73.75%
2015NZ$0.58 B-23.19%
2014NZ$0.75 B50.6%
2013NZ$0.50 B296.36%
2012NZ$0.12 B-25.93%
2011NZ$0.17 B-50.13%
2010NZ$0.34 B-19.48%
2009NZ$0.42 B1759.42%
2008NZ$22.96 M-90.41%
2007NZ$0.23 B-69.08%
2006NZ$0.77 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of Vanda Pharmaceuticals was reported to be:

NZ$0.73 Billion
by Nasdaq info icon info icon
NZ$0.73 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$909.08 B 122,773.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$473.68 B 63,924.52%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$249.60 B 33,637.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.543 T 208,558.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$457.32 B 61,712.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$186.07 B 25,050.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
NZ$10.18 M-98.62%๐Ÿ‡บ๐Ÿ‡ธ USA